Latest Lonza News & Updates

See the latest news and media coverage for Lonza. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Lonza

Dedicated CDMO serving the healthcare industry

lonza.com
Headquarters
Basel, Switzerland
Founded year
1897
Company type
Public company
Number of employees
15,000+

Last updated

Latest news about Lonza

In short: Lonza reported strong 2025 growth with CHF 6.5 billion in sales, initiated a $3 billion divestment of its CHI unit, and accelerated its CDMO strategy.

Company announcements

  • Lonza

    Lonza delivers strong Q1 2026 performance

    Confirms full-year outlook with 11-12% sales growth and EBITDA margin above 32%. Completes transformation to pure-play CDMO via CHI divestment.

  • Lonza

    Lonza announces 2026 AGM results

    All board motions approved. Jean-Marc Huët re-elected as Chair. New board members elected. CHF 5.00 dividend approved, up 25%.

  • Lonza

    Lonza licenses SYNtecan technology to Bristol Myers Squibb

    Agreement grants BMS exclusive access to SYNtecan linker-payload platform for an undisclosed ADC target. Lonza eligible for upfront, milestone, and royalty payments.

  • Lonza

    Lonza achieves 2030 GHG intensity target early

    Lonza generates 50% more value with same GHG footprint since 2018, updates target to 2021 base year, and reaches 100% renewable electricity in US, Europe, China by 2026.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Lonza

Track Lonza and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.